Skip to main content
Clinical Trials/CTRI/2021/02/031395
CTRI/2021/02/031395
Recruiting
Phase 1

A randomized controlled clinical study to evaluate the efficacy of madhu kumari lepa in management of periorbital hyperpigmentation

purva verma self0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: L80-L99- Other disorders of the skin and subcutaneous tissue
Sponsor
purva verma self
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
purva verma self

Eligibility Criteria

Inclusion Criteria

  • 1\.subjects diagnosed with periorbital hyperpigmentation will be included
  • 2\.subjects of age group 21 to 50 years will be included irrespective of their gender ,religion,and socio economic status
  • 3\.subjects who are willing to participate in the study
  • 4\.subjects with periorbital hyperpigmentation caused due to constitutional causes

Exclusion Criteria

  • 1\.subjects taking photosensitizing drugs like NASIDS,anti \-histamines,oral contraceptives,sulphonamides etc
  • 2\.Chloasma/melasma,post \-inflammatory hyperpigmentation will be excluded
  • 3\.smoking ,alcoholism
  • 5\.subjects suffering from any other systemic illness

Outcomes

Primary Outcomes

Not specified

Similar Trials